162
Participants
Start Date
July 31, 2011
Primary Completion Date
February 29, 2012
Study Completion Date
March 31, 2012
DA-9501
Dexmedetomidine hydrochloride variable dose
placebo
Asahikawa Medical University Hospital, Asahikawa
Hyogo Prefectural Amagasaki Hospital, Amagasaki
Tsukuba University Hospital, Tsukuba
Kagoshima University Medical and Dental Hospital, Kagoshima
Japanese Red Cross Kyoto Daini Hospital, Kyoto
University of Miyazaki Hospital, Miyazaki
Okayama University Hospital, Okayama
Yuaikai Toyomijo Chuo Hospital, Toyomijo
Kansai Medical University Hirakata Hospital, Hirakata
Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Osaka
Osaka Police Hospital, Osaka
Osaka Saiseikai Nakatsu Hospital, Osaka
Osaka University Dental Hospital, Suita
Saitama Medical University International Medical Center, Hidaka
Shimane University Hospital, Izumo
Tottori University Hospital, Yonago
Keio University Hospital, Tokyo
Tokyo Women's Medical University Hospital, Tokyo
Collaborators (1)
Maruishi Pharmaceutical
INDUSTRY
Hospira, now a wholly owned subsidiary of Pfizer
INDUSTRY